Subscribe to the daily news Sign in
En
Invensify and Senpex Partner to Enhance Delivery of Temperature-Sensitive Pharmaceuticals
11 September 2024

Invensify and Senpex Partner to Enhance Delivery of Temperature-Sensitive Pharmaceuticals

Invensify, Inc. (Invensify), a global provider of innovative and energy-efficient cold chain shipping solutions, has announced a strategic partnership with Senpex, a nationwide last-mile delivery service provider, to improve the delivery of temperature-sensitive pharmaceuticals. This partnership will see Senpex incorporating Invensify's cutting-edge Insuridge shipping container into their logistics operations.

The Insuridge temperature-controlled shipping container is an innovative alternative to traditional passive shippers that rely on dry ice or phase-change materials. Utilizing advanced semiconductor technology, the Insuridge container ensures the safe transportation of temperature-sensitive materials, such as DNA, RNA, intact cells, and pharmaceuticals.

"We are thrilled to partner with Senpex and provide them with our cutting-edge Insuridge shipping containers," said Faizan Ahmed, CEO and Founder of Invensify. "Our solution aligns perfectly with Senpex's commitment to embracing advanced technologies and improving the reliability of their courier services. Together, we are transforming the last-mile delivery of temperature-sensitive pharmaceuticals, ensuring the integrity and safety of these critical products."

Senpex, with a proven track record of over 500,000 successful deliveries since its inception in 2017, offers a wide range of courier and logistics services across various industries. By incorporating Invensify's Insuridge shipping containers, Senpex aims to better address the challenges of maintaining cold chain integrity during deliveries.

"Senpex has always prioritized the adoption of innovative technology to enhance our courier service and streamline operations," said Anar Mammadov, CEO and co-founder of Senpex Technology. "Partnering with Invensify to provide FDA 21 CFR compliant tracking and monitoring of temperature-sensitive pharmaceutical shipments was a natural decision. We believe this collaboration will significantly contribute to our mission of delivering affordable, convenient, and trusted shipping services to industries of all sizes."
Related tags: cold chain
Share

Related news

Ti Cold completes third cold storage facility for Agile in New York
Ti Cold has completed a new cold storage facility for Agile Cold Storage, marking the third building developed for the growing third-party logistics (3PL) provider. The 132,865-square-foot (ap...
18 Dec 2025
Pfenning Logistics expands in Germany with new cold storage facility
Pfenning logistics group has launched construction of its new cold chain logistics center “freshcube Osthessen” in Bad Hersfeld with a symbolic groundbreaking ceremony. The facility will cover ...
19 Nov 2025
GCCA supports cold chain development in West Africa through mentorship
The Global Cold Chain Foundation (GCCF) has launched a mentorship program connecting cold chain experts with local operators in West Africa, as part of the USDA-funded Emerging Markets Program. Sin...
23 Oct 2025
Review explores challenges and innovations in sustainable cold stor...
A new review published in Food Research International presents a comprehensive analysis of current challenges and future opportunities in postharvest cold storage for fresh produce. The internation...
28 Oct 2025
BioLife Solutions sells cold chain logistics unit to Peli BioThermal
BioLife Solutions, a US-based provider of cell processing tools for the cell and gene therapy (CGT) sector, has announced the sale of its cold chain logistics subsidiary SAVSU Cleo Technologies, LL...
09 Oct 2025
Carrier Ventures invests in Net Feasa to expand cold chain visibili...
Carrier Global Corporation announced that its venture capital arm, Carrier Ventures, has invested in Ireland-based Net Feasa to enhance real-time cold chain visibility across maritime shipping rout...
23 Oct 2025